Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Reaches New 1-Year Low – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $14.01 and last traded at $14.01, with a volume of 1911 shares. The stock had previously closed at $14.63.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on TLX shares. UBS Group assumed coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a “buy” rating and a $21.00 price objective on the stock. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The company has a fifty day moving average price of $15.61.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.